Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence by Muhammad Miftahussurur et al.
RESEARCH ARTICLE
Gastroesophageal reflux disease in an area
with low Helicobacter pylori infection
prevalence
Muhammad MiftahussururID1,2,3☯*, Dalla Doohan2,3☯, Iswan Abbas Nusi1, Pangestu Adi3,
Yudith Annisa Ayu Rezkitha3,4, Langgeng Agung WaskitoID2,3, Kartika Afrida Fauzia2,3,
Taufan Bramantoro5, Ummi Maimunah1, Husin Thamrin1, Safitri Indah Masithah3,
Sukadiono Sukadiono4, Tomohisa Uchida6, Maria Inge Lusida3, Yoshio Yamaoka1,7*
1 Gastroentero-Hepatology Division, Department of Internal Medicine, Faculty of Medicine-Dr. Soetomo
Teaching Hospital, Universitas Airlangga, Surabaya, Indonesia, 2 Department of Environmental and
Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan, 3 Institute of Tropical Disease,
Universitas Airlangga, Surabaya, Indonesia, 4 Muhammadiyah University of Surabaya, Surabaya, Indonesia,
5 Department of Dental Public Health, Faculty of Dental Medicine, Universitas Airlangga, Surabaya,
Indonesia, 6 Department of Molecular Pathology, Oita University Faculty of Medicine, Yufu, Japan,
7 Department of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E. DeBakey
Veterans Affairs Medical Center, Houston, Texas, United States of America
☯ These authors contributed equally to this work.
* yyamaoka@oita-u.ac.jp (YY); miphto@yahoo.co.id (MM)
Abstract
The association between gastroesophageal reflux disease (GERD) prevalence and its risk
factors in an area with low Helicobacter pylori prevalence is important to clarify. We ana-
lyzed the prevalence of GERD and risk factors in an area of Indonesia with low prevalence
of H. pylori infection. We recruited 104 dyspeptic patients who underwent endoscopy in
Surabaya. Patients were diagnosed with GERD based on the Los Angeles classification.
We evaluated gastric biopsy specimens and measured serum pepsinogen levels. Interleu-
kin polymorphisms were evaluated by polymerase chain reaction-restriction fragment length
polymorphism. Of 104 patients, 56 (53.8%) were endoscopically found to have GERD, with
most categorized as grade A; 48 (46.2%) were classified as non-GERD. Higher economic
status, smoking, and a history of proton-pump inhibitor use significantly increased the risk of
GERD. GERD Questionnaire scores showed a positive correlation with GERD (P < 0.001).
An association was found between antral atrophic gastritis and GERD (P = 0.030), and
patients with GERD more frequently had severe antral atrophy than nonerosive reflux dis-
ease (P = 0.018). We found an association between pepsinogen I/II levels and GERD
(P = 0.047), but with low accuracy. IL-1β -511 TT and CT were predominant among the IL-
1β -511 genotypes, and IL-8–251 AT and TT were predominant among the IL-8–251 geno-
types. In conclusion, we found a high prevalence of GERD in an area with low prevalence of
H. pylori infection, which could be associated with acid reflux. Smoking, history of proton-
pump inhibitor use, and higher economic group significantly increased the risk of GERD.
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Introduction
Helicobacter pylori infection, the most prevalent human chronic bacterial infection [1], modi-
fies gastric acid secretion, affecting gastroduodenal disease pathogenesis, including gastro-
esophageal reflux disease (GERD) [2], GERD is a condition wherein gastric reflux or
complications expose the gastric contents to the esophageal squamous epithelium [3].
The hypothesis regarding an H. pylori–GERD association has been reinforced by the paral-
lel of increasing GERD incidence with decreasing H. pylori infection prevalence in Asia [4, 5].
However, some authors consider GERD as an acid reflux-related disease and H. pylori as a bio-
logical secretory or anti-secretory agent [6, 7]. Acid secretion in corpus predominant gastritis
decreases, thus inhibiting severe reflux development, contrary to antral predominant gastritis.
A meta-analysis was also unable to prove a significant association between H. pylori eradica-
tion and GERD development [8]. The prevalence and risk factors for GERD in an area of low
H. pylori prevalence must be examined to provide more information regarding GERD–H.
pylori association.
Reflux disease is classified into GERD and non-erosive reflux disease (NERD) [9]. GERD is
diagnosed based on the presence of mucosal breaks or ulcerations found during an endoscopic
examination. NERD is defined as the presence of reflux-related symptoms in the absence of
esophageal mucosal breaks or ulcerations during endoscopy examination [9]. Intraesophageal
pH monitoring also facilitates GERD diagnoses in the absence of endoscopically visible lesions.
These methods are less comfortable for patients and less feasible in some areas. Indonesia has
a population of more than 255.5 million people in 2015 living on thousands of islands (Statis-
tics Indonesia, http://www.bps.go.id/); however, only 313 hospitals have gastrointestinal
endoscopy systems, and most are located on the main island, Java [10]. Additionally, only two
centers have intraesophageal pH monitoring to confirm GERD diagnoses (Dr. Miftahussurur,
personal communication). Thus, an indirect method of diagnosing GERD, such as the GERD
Questionnaire (GERDQ), is one option, which has recently been validated in several countries
and is reportedly a useful complementary diagnosis tool for GERD in primary care [11–13].
Several lifestyle factors, such as smoking [14, 15], table salt consumption [15], obesity [16,
17], older age [14], irregular diet, and diet variety [18] have been established as risk factors for
GERD. Inflammation mediators may play a more important role in GERD pathogenesis than
caustic acid injury [19]. Interleukin (IL)-1β, an important proinflammatory cytokine that
increases in the mucosal tissue in esophagitis and Barrett’s esophagus [20], could be correlated
with decreased esophageal contraction, which is caused by acetylcholine release inhibition
from neurons [21]. Research on Taiwanese patients found that IL-1β polymorphisms affect
gastritis and erosive reflux esophagitis [22]. IL-8 mediated chemotaxis in neutrophils is found
to be involved in both the acute and chronic inflammation processes [23]. A significant associ-
ation has been shown between IL-8 mRNA in esophageal mucosa and reflux esophagitis based
on the Los Angeles classification, and a higher IL-8 mRNA level has been detected in patients
with GERD compared with those with a noninflamed esophagus [20, 24].
To our knowledge, reports investigating GERD in Indonesia are scarce [25, 26], and no study
has analyzed the risk factors for GERD considering H. pylori infection status. This study investi-
gated GERD prevalence in areas with low rates of H. pylori infection and risk factors for GERD.
Materials and methods
Study participants
A total of 113 patients with dyspeptic symptoms (e.g. epigastric pain, heart burn, and regurgi-
tation) underwent upper endoscopy between October 2014 and November 2015. We excluded
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a total 9 patients including 3 patients due to partial gastric resection history, and also two and
four patients associated with antibiotic and proton-pump inhibitor (PPI) consumptions,
respectively. Finally, 104 participants which were predominantly Javanese included in this
study. During the 2 weeks before the endoscopy, these patients had not taken any nonsteroidal
anti-inflammation drug (NSAID), PPI, antibiotic, and histamine receptor antagonist. On the
day of the endoscopy, we collected the patient’s fasting serum and stored it at −20 ˚C. Sociode-
mographic data were collected during the interview.
Ethical approval was obtained from the Ethics Committee of Dr. Soetomo Teaching Hospi-
tal (Surabaya, Indonesia) and Oita University Faculty of Medicine (Yufu, Japan). Prior to the
data collection, the study was explained to the patients, who then provided a written informed
consent document based on the guidelines of the Declaration of Helsinki.
Endoscopic evaluation and GERD Questionnaire
GERD was diagnosed by endoscopy. To evaluate the severity of reflux esophagitis, an endo-
scopic examination was performed on all the recruited patients by two experienced endosco-
pists (PA and IAN). During each patient’s endoscopy session, we collected three gastric biopsy
specimens, two of which was taken from the lesser curvature of the antrum approximately
3 cm from the pyloric ring, and the other from the greater curvature of the corpus (8–10 cm
from the esophagogastric junction). One of homogenized antral biopsy specimens was inocu-
lated onto selective agar plates and incubating the plates up to ten days in microaerophilic
environment (10% O2, 5% CO2, and 85% N2) at 37˚C to isolate H. pylori as previously
described [27]. Two other gastric biopsies were used for histology examination. The esophagi-
tis evaluation was based on the Los Angeles classification [28]. Grade A represents one or
more mucosal breaks confined to mucosal folds (not more than 5 mm in length for each);
grade B represents at least one mucosal break greater than 5 mm; grade C represents a contin-
uous mucosal break between the tops of two mucosal folds but not circumferential; and grade
D is a circumferential mucosal break.
Before undergoing endoscopy, the patients were asked to complete the GERDQ, which is a
six-item questionnaire used as an indirect method to help diagnose GERD [29]. The items
include questions regarding symptoms of heartburn, regurgitation, epigastric pain, nausea, dif-
ficulty getting a good night sleep, and the frequency of taking reflux symptom medication dur-
ing the previous 7 days. The frequency of positive predictors of GERD was determined using
the four-grade Likert scale (0–3) and the negative predictors of GERD by the reversed Likert
scale (3–0), resulting a total possible score from 0 to 18. The positive predictors are the con-
sumption of over-the-counter medication for reflux symptoms, regurgitation, heartburn, and
sleep disturbance, whereas the two negative predictors are nausea and epigastric pain [12]. We
classified NERD as a condition when reflux-related symptoms are present in the absence of
esophageal mucosal breaks.
Histology, H. pylori status, and pepsinogen
We fixed biopsy materials in 10% formalin and embedded them in paraffin. May–Gru¨nwald–
Giemsa stain along with hematoxylin eosin stain was applied to the thin slices of paraffin-
embedded biopsy. On the basis of the updated Sydney system, an experienced pathologist
(TU) assessed the degree of inflammation, atrophy, and bacterial density in each specimen and
assigned to each one of four grades: 0, normal; 1, mild; 2, moderate; and 3, marked [30]. We
also assessed the stage of gastritis based on the Operative Link for Gastritis Assessment
(OLGA) system [31, 32]. We performed immunohistochemistry with anti-H. pylori antibody,
and H. pylori-positive cases were regarded as the specimens that had bacterial loads greater
GERD and H. pylori in Indonesia
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than or equal to grade 1 [30]. H. pylori infection diagnosis was concluded by the combined
result of three different tests: histology, culture, and immunohistochemistry. H. pylori-positive
cases were confirmed if at least one positive result was shown in these tests.
Pepsinogen (PG) I and II levels were assessed in the collected serum using a PG ELISA
(Eiken, Tokyo, Japan), following the manufacturer’s instructions.
Genotyping for interleukin polymorphisms
For DNA isolation, 100 μL of gastric homogenates was used and extracted using the phenol–
chloroform method. IL-1β and IL-8 polymorphisms were evaluated by polymerase chain reac-
tion-restriction fragment length polymorphism (PCR-RFLP) analysis. The primer sequence
and PCR condition are shown in Table 1. For genotyping of the IL-1β -511 polymorphism,
10 μL PCR products were digested with 3U AvaI (New England Biolabs Japan) and then incu-
bated at 37 ˚C for 3 h, resulting in 190 and 114 bp (-511 CC); 304, 190, and 114 bp (-511 CT);
or they remained intact (-511 TT) [33]. For genotyping of the IL-8–251 polymorphism, 10 μL
PCR products were digested with 3U of MfeI (New England Biolabs Japan) and then incubated
at 37 ˚C for 1 h, which resulted in 449 and 92 bp (-251 AA); 541, 449, and 92 bp (-251 AT); or
they remained intact (-251 TT) [34]. The digested product was confirmed by 2% agarose gel
electrophoresis.
Statistical analysis
The statistical analysis was performed using the SPSS statistical software package version 18.0
(SPSS, Inc., Chicago, IL, USA). The categorical data were analyzed using the chi-squared test
or Fisher’s exact test. Statistical significance was determined when P was less than 0.05. The
expected genotype frequencies and observed genotype frequencies were calculated using the
Hardy–Weinberg Equilibrium equation (p2 + 2pq + q2 = 1) and tested for compliance using
the chi-squared test. Binary and multiple logistic regression were used to analyze the odds
ratio (OR) with 95% confidence interval (CI) of the risk factors that could have an association
with the development of GERD. The Hosmer–Lemeshow goodness-of-fit test was used to eval-
uate the fit of the model.
Results
GERD prevalence and risk factors
Of 104 patients, 56 (53.8%) were found by endoscopy to have GERD, and 48 patients (46.2%)
were classified as non-GERD. According to the LA Classification, 50 were categorized as grade
A (89.3%), 4 were categorized as grade B (7.1%), and only two patients were categorized as
grade C (3.6%). Forty-eight patients without esophagitis were regarded as non-GERD.
Table 1. Primer sequence and PCR condition.
Gene Primer Sequence Amplification Cycles
IL-1β -511 94 ˚C for 5 min, then 35 cycles of 94 ˚C for 1 min, 55 ˚C for 1 min, 72 ˚C for 1 min, and 72 ˚C for 7 min
Forward 50-TGGCATTGATCTGGTTCATC-30
Reverse 50-GTTTAGGAATCTTCCCACTT-30
IL-8–251 95 ˚C for 3 min, then 35 cycles at 95 ˚C for 30 s, 54 ˚C for 1 min, 72 ˚C for 1 min, and 72 ˚C for 7 min
Forward 50-TCATCCATGATCTTGTTCTAA-30
Reverse 50-GGAAAACGCTGTAGGTCAGA-30
https://doi.org/10.1371/journal.pone.0205644.t001
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Table 2 shows the adjusted OR calculated for the occurrence of GERD, which used the low-
est prevalence of GERD as the reference. The mean age of the patients was 46.42 ± 13.83 years
(range, 17–77 years). The young (<30 years of age) had the highest risk of GERD, although it
was not significant (OR = 2.57, P = 0.148). Of the male patients, 28 (28/44; 63.6%) had GERD,
and they showed a higher risk tendency than those in the female group (28/60, 46.7%,
P = 0.088). The prevalence of GERD in the patients with obesity and overweight (13/21; 61.9%
and 7/10; 70.0%, respectively) was higher than in those who were normal and underweight
(31/60; 51.7% and 5/13; 38.5%). However, the distribution of BMI in the GERD and non-
GERD groups showed no significant association (P = 0.391). The high and middle economic
groups based on monthly income (1 USD = 13.500 rupiah) had 4.08 and 3.08 times the risk of
GERD, respectively, than the low economic group (P = 0.021 and P = 0.046, respectively).
There was an association between obesity and economic status (P = 0.045, r = 0.197). Smoking
was shown to be an important factor in GERD development, given that more than three-quar-
ters of the patients with a history of smoking cigarettes had GERD (19/25; 76.0%) and one-
third of the patients with GERD had a history of smoking (19/56; 33.9%). Statistical analyses
also showed that the smokers had a significantly higher risk of developing GERD compared
with nonsmokers (OR = 3.60, P = 0.014). The history of PPI usage also positively increased the
risk of GERD, by 2.52 times (P = 0.027). After adjusting for age and sex, it was found that high
and middle economic status, smoking habits, and the history of PPI use significantly increased
the risk of GERD (OR = 8.49, OR = 6.45, OR = 3.22, and OR = 3.12, P< 0.05, respectively).
However, in the multivariate analysis using logistic regression, only high economic status and
PPI use were independent risk factors for GERD. There was no significant association between
GERD and ethnicity, religion, marital status, alcohol consumption, antibiotic, or NSAID
intake, diabetes mellitus, and hypertension (P> 0.05). When we diagnosed H. pylori infection
based on the combination of culture and histology-immunohistochemistry, we only detected
H. pylori as positive in two patients (2/104; 1.9%), which was similar in prevalence to the previ-
ous study [27, 35]. Thus, we could not measure their association with GERD due to an insuffi-
cient number of cases to analyze. However, all H. pylori-infected patients were GERD positive;
one without atrophy and one with antral atrophy in the histological analysis.
Endoscopic findings and GERDQ
Most of the patients had low GERDQ scores; for example, 69.2% (72/104) had scores� 3.
When we compared the occurrence of the symptoms listed in the GERDQ, as we had expected,
heartburn, regurgitation, epigastric pain, nausea, and sleep disorder symptoms were signifi-
cantly higher in the patients with GERD than in those without (P = 0.008, P = 0.027, P = 0.002,
P< 0.001, P = 0.019, respectively) (Table 3). The GERDQ scores showed a positive correlation
with GERD events (P< 0.001). Furthermore, the results of the correlation between total
GERDQ scores and the occurrence of GERD based on the Spearman’s rank correlation model
showed that an increasing score reflects increased risk of GERD (r = 0.616, p< 0.001). The
optimal cut-off points for the GERDQ score using the receiver operating characteristic (ROC)
was 1.5, and sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV), and accuracy were 75.0%, 75.0%, 77.8%, 72.0%, and 75.0%, respectively (area under
the curve [AUC] 0.850; 95% CI, 0.776–0.924). We found 25 patients with GERD symptoms
based on the GERDQ but with normal mucosal appearance by endoscopy, who are categorized
as having NERD. In contrast, we found six patients with no symptoms of GERDQ, but who
had positive mucosal breaks on endoscopy, including one patient with GERD grade C. Patients
with GERD had significantly higher GERDQ scores than those with NERD (P< 0.001).
GERD and H. pylori in Indonesia
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Table 2. Association of demographic data and interleukin polymorphism with GERD status.
Variables Total GERD (%) Total Non-GERD (%) Crude OR OR (95% CI) P Value
Sex
Male 28 (63.6) 16 (36.4) 2.00 0.902–4.436 0.088
Female 28 (46.7) 32 (53.3) 1.00
Age
<30 10 (66.7) 5 (33.3) 2.57 0.714–9.255 0.148
31–40 10 (50.0) 10 (50.0) 1.29 0.419–3.944 0.660
41–50 12 (57.1) 9 (42.9) 1.71 0.564–5.208 0.342
>60 10 (62.5) 6 (37.5) 2.14 0.627–7.329 0.224
51–60 14 (43.8) 18 (56.3) 1.00
BMI
<18.5 5 (38.5) 8 (61.5) 1.00
18.5–24.9 31 (51.7) 29 (48.3) 1.71 0.502–5.832 0.391
25–29.9 13 (61.9) 8 (38.1) 2.60 0.627–10.786 0.188
>30 7 (70.0) 3 (30.0) 3.73 0.646–21.577 0.141
Economic
< Rp1,5M 6 (28.6) 15 (71.4) 1.00
Rp 1.5M–Rp 5M 29 (58.0) 21 (42.0) 3.08 1.018–9.289 0.046�
> Rp 5M 21 (63.6) 12 (36.4) 4.08 1.241–13.431 0.021�
Smoking
Yes 19 (76.0) 6 (24.0) 3.60 1.298–9.955 0.014�
No 37 (46.8) 42 (53.2) 1.00
Alcohol
Yes 6 (85.7) 1 (14.3) 5.64 0.654–48.619 0.115
No 50 (51.6) 47 (48.5) 1.00
Diabetes
Yes 6 (75.0) 2 (25.0) 2.76 0.530–14.366 0.228
No 50 (52.1) 46 (47.9) 1.00
Hypertension
Yes 14 (60.9) 9 (39.1) 1.44 0.562–3.713 0.445
No 42 (51.9) 39 (48.2) 1.00
Ethnicity
Java 38 (57.6) 28 (42.4) 1.81 0.740–4.422 0.193
Other 4 (66.7) 2 (33.3) 2.67 0.417–17.046 0.300
Dayak 2 (50.0) 2 (50.0) 1.33 0.164–10.867 0.788
Chinese 12 (42.9) 16 (57.1) 1.00
Religion
Islam 43 (60.6) 28 (39.4) 4.61 0.868–24.464 0.073
Christian 11 (55.0) 9 (45.0) 3.67 0.590–22.783 0.163
Catholic 2 (25.0) 6 (75.0) 1.00
Other 0 (0.0) 5 (100)
Marital Status
Married 48 (54.6) 40 (45.5) 1.20 0.413–3.485 0.737
Not married 8 (50.0) 8 (50.0) 1.00
Toilet
Toilet 55 (53.4) 48 (46.6)
Non-toilet 1 (100) 0 (0.0)
PPI
(Continued)
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Table 2. (Continued)
Variables Total GERD (%) Total Non-GERD (%) Crude OR OR (95% CI) P Value
Yes 41 (62.1) 25 (37.9) 2.52 1.109–5.703 0.027�
No 15 (39.5) 23 (60.5) 1.00
Antibiotic
Yes 11 (55.0) 9 (45.0) 1.60 0.398–2.822 0.908
No 45 (53.6) 39 (46.4) 1.00
NSAID
Yes 15 (62.5) 9 (37.5) 1.59 0.622–4.040 0.334
No 41 (51.3) 39 (48.8) 1.00
Sambal Intake
Yes 28 (56.0) 22 (44.0) 1.18 0.546–2.559 0.672
No 28 (51.9) 26 (48.2) 1.00
H. pylori infection
Positive 2 (100) 0 (0.0)
Negative 54 (52.9) 48 (47.1)
Antrum Atrophy
Yes 11 (84.6) 2 (15.4) 0.18 0.037–0.848 0.030�
No 45 (49.5) 46 (50.6) 1.00
Corpus Atrophy
Yes 1 (50.0) 1 (50.0) 1.17 0.071–19.225 0.912
No 55 (53.9) 47 (46.1) 1.00
OLGA Score
Normal 44 (49.4) 45 (50.6) 1.00
Stage 1 12 (80.0) 3 (20.0) 4.09 1.080–15.493 0.038�
Stage 2 0 (0.0) 0 (0.0)
Stage 3 0 (0.0) 0 (0.0)
Stage 4 0 (0.0) 0 (0.0)
IL-1β Polymorphism
TT 21 (48.8) 22 (51.2) 1.00
CC 14 (56.0) 11 (44.0) 1.33 0.495–3.590 0.569
CT 21 (58.3) 15 (41.7) 1.47 0.601–3.580 0.400
T Carrier IL-1β
T carrier 32 (46.4) 37 (53.6) 1.00
CC 24 (68.6) 11 (31.4) 1.12 0.454–2.771 0.804
C Carrier IL-1β
TT 21 (48.8) 22 (51.2) 1.00
C carrier 35 (57.4) 26 (42.6) 1.41 0.644–3.090 0.390
IL-8 Polymorphism
TT 18 (48.7) 19 (51.4) 1.35 0.424–4.323 0.610
AT 31 (62.0) 19 (28.0) 2.33 0.759–7.158 0.139
AA 7 (41.2) 10 (58.8) 1.00
T Carrier IL-8
T carrier 49 (60.5) 38 (39.5) 1.84 0.642–5.289 0.256
AA 7 (41.2) 10 (58.8) 1.00
A Carrier IL-8
TT 18 (48.7) 19 (51.4) 1.00
A carrier 38 (56.7) 29 (43.3) 1.38 0.618–3.096 0.430
�Statistically significant when P< 0.05.
https://doi.org/10.1371/journal.pone.0205644.t002
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Histology and GERD
On the basis of the updated Sydney system, we analyzed the histopathological scores in the
antrum and corpus, and their association with GERD. There was no association between acute
(neutrophil activity) and chronic gastritis (mononuclear cells) with GERD (P> 0.05). Among
104 biopsies, 13 (12.5%) and 2 (1.9%) patients had glandular atrophy in the antrum and cor-
pus, respectively. There was a significant association between antral atrophic gastritis with the
presence of GERD (P = 0.030). However, there was no significant association between corpus
atrophic gastritis with GERD (P = 0.912) (Table 2). Moreover, when we used the OLGA score
parameter, for OLGA stage 1 there was a 4.09 times higher risk of GERD than for OLGA stage
0 (P = 0.038). In addition, patients with GERD had significantly more severe antral atrophic
gastritis than those with NERD (P = 0.018). Furthermore, when we excluded patients with H.
pylori, the association between GERD and antral atrophic gastritis and OLGA scores was con-
sistent (P = 0.025 and P = 0.039, respectively).
Pepsinogen vs GERD
We could only collect 97 serum samples due to insufficient samples from the remaining seven
patients. The comparison of PG levels among the patients with and without GERD is shown in
Table 4. We found an association between PG I/II levels and GERD (P = 0.047). However,
there was no association between PG I and PG II levels. When we calculated the best cut-off
point using ROC for the PG I/II ratio for detecting GERD, we found the level was 6.25, and
sensitivity, specificity, PPV, NPV, and accuracy were 66.0%, 59.1%, 66.0%, 59.1%, and 62.9%,
respectively (AUC 0.626; 95% CI, 0.514–0.738).
IL-1β and IL-8 polymorphism genotyping
We found three different allelic patterns based on IL-1β -511 genotyping. In total, 43 of 104
patients (41.4%) were homozygous for the wild-type allele (-511 TT), 25 of 104 patients
(24.0%) were homozygous for the mutated allele (-511 CC), and 36 of 104 patients (34.6%)
were heterozygous (-511 CT). On the basis of the IL-8–251 genotyping result, 37 of 104
Table 3. Gastrointestinal symptoms based on GERD Questionnaire.
Symptoms Endoscopic Finding Total GERD (n = 56) Non-GERD (n = 48) P value�
Grade A Grade B Grade C
Heartburn + 17 1 0 18 (32.1%) 5 (10.4%) 0.008��
− 33 3 2 38 (67.9%) 43 (89.6%)
Regurgitation + 8 0 0 8 (14.3%) 1 (2.1%) 0.027��
− 42 4 2 48 (85.7%) 47 (97.9%)
Epigastric Pain + 34 4 1 39 (69.6%) 18 (37.5%) 0.002��
− 16 0 1 17 (30.4%) 30 (62.5%)
Nausea + 33 2 1 36 (64.3%) 8 (16.7%) <0.001��
− 17 2 1 20 (35.7%) 40 (83.3%)
Sleep Disorder + 6 0 0 6 (10.7%) 0 (0.0%) 0.019��
− 44 4 2 50 (89.3%) 48 (100%)
Drug Intake + 5 0 0 5 (8.9%) 0 (0.0%) 0.105
− 45 4 2 51 (91.1%) 48 (100%)
�P value of GERD with symptoms vs non-GERD with symptoms.
��P < 0.05.
https://doi.org/10.1371/journal.pone.0205644.t003
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patients (35.6%) were homozygous for the wild-type allele (-251 TT), 17 of 104 patients
(16.4%) were homozygous for the mutated allele (-251 AA), and 50 of 104 patients (48.1%)
were heterozygous (-251 AT).
In this genetic population study, we used the Hardy–Weinberg equation (p2 + 2pq + q2 = 1)
to calculate the difference between observed genotype frequencies in this population and the
frequencies predicted by the equation. The expected p value of IL-1β -511 (which is represents
the T allele) was 0.59, and the expected q value (which represents the C allele) was 0.41. By
using the same calculation, we found that the expected p value of IL-8–251 (which is represents
T allele) was found to be 0.60 and the expected q value (which is represents A allele) was 0.40.
Comparison of observed genotype frequencies and the predicted genotype frequencies were
performed using the chi-squared test. By comparing the observed and predicted genotype fre-
quencies, we found that genetic variants of IL-1β -511 and IL-8–251 conformed to the Hardy–
Weinberg law (χ2 = 2.48, P = 0.115, and χ2 = 0.01, P = 0.920, respectively). The genotype fre-
quencies are shown in Table 5. However, there was no statistically significant association
between the IL-1β -511, IL-8–251 polymorphisms, and GERD (P = 0.680 and P = 0.242,
respectively).
Discussion
Although GERD has become one of the most common gastroduodenal disorders, its diagnosis
is still a major challenge due to the absence of a gold standard for its definitive diagnosis. In
this study, we have revealed that more than half of dyspeptic patients in areas with low preva-
lence of H. pylori were found to have GERD by endoscopy. However, more than three-quarters
of these were categorized as having a mild grade of GERD which may associated with the
severity of risk factors including mild atrophy of antrum. The prevalence of GERD in this
report was greater than in previous studies in Indonesia. The previous study conducted in
Jakarta revealed that 22.8% of the patients who had undergone upper gastrointestinal endos-
copy had esophagitis [36]. Another study in Jakarta showed that the prevalence of esophagitis
had increased from 5.7% in 1997 to 25.18% in 2002 [37].
Table 4. The comparison of pepsinogen levels between patients with and without GERD.
PG GERD Non-GERD P value�
PG I
Minimum value 14.3 16
Maximum value 422 312
Mean PG I ± SD 94.78 ± 77.12 78.09 ± 56.86 0.295
PG II
Minimum value 2.2 3.4
Maximum value 53.9 35.7
Mean PG II ± SD 13.59 ± 10.32 12.17 ± 7.24 0.822
PG I/II
Minimum value 3.5 4.5
Maximum value 12 9.8
Mean PG I/II ± SD 6.86 ± 1.68 6.23 ± 1.31 0.047��
�GERD vs non-GERD.
��Statistically significant when P< 0.05.
PG, pepsinogen.
https://doi.org/10.1371/journal.pone.0205644.t004
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The low prevalence of H. pylori among the dyspeptic patients in our study suggests that
Indonesia is a good model for analyzing the controversies regarding the effect of H. pylori
infection on acid reflux-related diseases. In fact, in two patients found to be H. pylori-positive,
both had been diagnosed with GERD. Antral atrophic gastritis was significantly associated
with non-GERD patients, suggesting that the antral atrophy might be a protective condition
against GERD [38–41]. In contrast, our result showed that the higher OLGA scores had a
higher risk to develop GERD. The positive association might be also attributed by the involve-
ment of corpus atrophic gastritis. In concordance with the results, there was a significant asso-
ciation between PG I and PG II ratio as a biomarker of gastric mucosal status with GERD.
Therefore, acid reflux-related GERD may be more important than H. pylori. Although our
study proposed the best cut-off point for predicting GERD using the PG I/II ratio, the accuracy
is low, suggesting that PG may not be useful for screening tests to detect patients with GERD
in areas where endoscopic facilities are scarce, including Indonesia.
We found that the reflux esophagitis symptoms that were mentioned in the GERDQ, such
as heartburn, regurgitation, epigastric pain, nausea, and sleep disturbance, were more frequent
in the patients with GERD than in those without, with statistical significance. The total
GERDQ scores also showed a positive correlation with GERD events, suggesting a benefit in
distinguishing reflux esophagitis symptoms. However, mucosal breaks were found in six
patients by endoscopy, without any symptoms having been mentioned in the GERDQ. More-
over, we found a low point for the optimal cut-off for GERDQ, indicating that GERDQ might
not be suitable or sufficiently sensitive to distinguish GERD for the Surabaya population.
These results are not surprising because the GERDQ showed wide variations in sensitivity and
specificity when used in different countries, such as high sensitivity in China (87.7%) [42], but
intermediate and low sensitivity in Norway and Japan (66% and 34%, respectively) [12, 43]. A
previous study in Medan, a high prevalence area for H. pylori infection in Indonesia, had also
shown that GERDQ was too insensitive for GERD diagnosis (49%), although with a higher cut-
off value [44].
Table 5. Genotype frequencies of IL-1β -511 and IL-8–251 polymorphisms.
Genotypes Total (%) GERD (% within GERD) Non-GERD (% within non-GERD)
IL-1β -511 104 56 48
TT 43 (41.4) 21 (37.5) 22 (45.8)
CC 25 (24.0) 14 (25.0) 11 (22.9)
CT 36 (34.6) 21 (37.5) 15 (31.3)
T carrier 79 (76.0) 42 (75.0) 37 (77.1)
C carrier 61 (58.7) 35 (62.5) 26 (54.2)
Allele T frequency 122 (58.7) 63 (56.3) 59 (61.5)
Allele C frequency 86 (41.3) 49 (43.7) 37 (38.5)
IL-8–251 104 56 48
TT 37 (35.6) 18 (32.1) 19 (39.6)
AA 17 (16.3) 7 (12.5) 10 (20.8)
AT 50 (48.1) 31 (55.4) 19 (39.6)
T carrier 87 (83.7) 49 (87.5) 38 (79.2)
A carrier 67 (64.4) 38 (67.9) 29 (60.4)
Allele T frequency 124 (59.6) 67 (59.8) 57 (59.4)
Allele A frequency 84 (40.4) 45 (40.2) 39 (40.6)
https://doi.org/10.1371/journal.pone.0205644.t005
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A significant association was found between GERD and smoking; the patients who smoked
had a 3.60 times higher risk of developing GERD compared with nonsmokers. The risk is
higher than in a previous study that found the reflux symptom risk was 1.7 times higher for
smokers than for nonsmokers [15], suggesting the importance of smoking habits in the devel-
opment of GERD. Smoking cessation positively improved GERD and health-related quality of
life [45]; thus, it should be recommended for patients with GERD. In contrast to several studies
that reported acid suppression drugs as the first-line therapy for GERD due to the inhibition
of gastric acid production [46–48], we found that PPI use was positively correlated with
GERD. We should note that there were differing histories of PPI intake for each patient, such
as amount, dosage, duration of PPI consumption, and the time since PPI had been withdrawn,
which might contribute to the result. Rebound acid hypersecretion can also occur after with-
drawal of PPI therapy, thus inducing reflux-like symptoms [2, 49]. Men tended to be at higher
risk of GERD than women, indicating that male patients were more likely to develop reflux
esophagitis, which is consistent with previous studies [50]. The prevalence of GERD in the
overweight and obesity groups also tended to be higher than in the underweight and normal
groups, a result similar to several previous studies that had suggested the importance of BMI
in the development of GERD [16, 17]. An association between BMI and GERD could be
explained by the fact that abdominal obesity increases pressure on the stomach, consequently
promoting reflux [17]. Higher economic status has been associated with BMI, suggesting that
both factors could be concomitant for GERD development.
Although several studies have suggested that IL-1β -511 and IL-8–251 polymorphisms are
associated with the development of various gastroduodenal disease including GERD [20, 22,
24, 51–53], no statistically significant associations have been found between IL-1β -511 and IL-
8–251 polymorphisms and GERD in this study. This result might be due to the small number
of samples. It is also possible that the pathogenesis of GERD does not solely depend on inter-
leukin polymorphisms, but also on other mechanisms, such as vasoactive amines and peptides,
complement components, chemokines, and hormonal regulation [54]. We used the Hardy–
Weinberg equilibrium equation to determine whether the observed allele frequencies in the
population differs from the predicted allele frequencies. Hardy–Weinberg law states that allele
and genotype frequencies will remain constant from one generation to future generation in
absence of several evolutionary influences. Equilibrium is reached in the absence of selection,
mutation, and genetic drift [55]. Our results have shown that our population conformed to the
law for both the IL-1β -511 and IL-8–251 polymorphisms, suggesting little disturbing factors,
such as mutation, selection, gene migration, or genetic drift.
One of the limitations of this study was the relatively small sample size. In addition, we only
diagnosed GERD based on endoscopy without esophageal manometry and 24-h pH monitor-
ing, due to a lack of facilities. Other limitation is the local ethic committee allowed us to take
maximum three biopsy specimens, thus we could not followed a minimum standard biopsy as
Maastricht V/Florence Consensus Report which suggesting two biopsies from the antrum and
the body [56]. Similar limitation also occurred to discontinue antibiotics only two weeks, but
not at least 4 weeks before the test as the consensus [56]. We followed the guideline by Ameri-
can Society for Gastrointestinal Endoscopy for three gastric mucosal sampling [57], and used
one of them for culture. Our survey showed that the detection rate of H. pylori infection using
additional corporal biopsy specimens increased by 1–6% [58]. In addition, we obtained only a
small number of samples from Surabaya, the eastern part of Java and the largest city in Indone-
sia next after Jakarta; thus, our results cannot be generalized across Java or Indonesia. To yield
better corroboration of prevalence and risk factors for GERD in Indonesia, research with a
larger sample size across multiple regions would be necessary.
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Conclusion
We found a high prevalence of GERD in areas with low prevalence of H. pylori; thus, GERD
could instead be associated with acid reflux. The GERDQ might not be suitable or sufficiently
sensitive to distinguish GERD for the Surabaya population. We have confirmed that smoking,
history of PPI use, and higher economic group were significantly associated with increased
risk of GERD.
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S1 Table. GERD was diagnosed by endoscopy. NERD was defined as a condition when
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